Services enabled by this technology
Strain development and cell banking
Benefit from more than 30 years of innovation in microbial biotechnology and get access to our toolbox of strain design options which provide the greatest probability of delivering a commercially viable strain that meets product quality targets and titers suitable for future market demand.
GS Xceed® Gene Expression System
GS piggyBac® Transposon Technology
POTELLIGENT® CHOK1SV® Technology
bYlok® Bispecific Pairing Technology
Our R&D Center of Excellence
Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Visp remains our largest site in a global network of more than 30 sites and one of the most significant for research and development, development and manufacturing.
Our Visp site is a complex of industry-leading facilities specializing in the development and manufacture of products for pharmaceutical applications including mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our pioneering Ibex® Solutions services offering: Ibex® Solutions enables customers to accelerate their path throughout the complete biopharmaceutical lifecycle - from preclinical to commercial stages, from drug substance to drug product, all in one location.